To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
Scientific result | Antibiotics | Diagnosis
Researchers at the LERI (SPI / DMTS), together with the AP-HP, have developed two rapid and inexpensive immunological tests to detect antibiotic resistance. The novelty: the tests detect the activity of bacterial enzymes that hydrolyze extended-spectrum cephalosporins.
In recent years, the emergence of multi-resistant bacteria has accelerated, in particular due to the excessive use of antibiotics. Among them,
extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are of particular concern. Indeed, each year, these bacteria are responsible for 19% of hospital-acquired infections in the United States and also are associated with increased mortality and healthcare costs, according to the U.S. government agency Centers for Disease Control and Prevention (CDC).
Aware of the stakes, researchers from the
LERI (SPI/DMTS) have developed a recognized expertise in the development of test strips detecting CTX-M ESBLs, responsible for the inactivation by hydrolysis of
extended-spectrum cephalosporins (ESC) such as
cefotaxime (CTX). These strains were targeted because they emerged explosively in the 1990s and now represent 98% of ESBL in France.
Among the tests developed, the
CTX-M MULTI test, marketed by the NG-Biotechcompagny, has already proved its worth in 2017 (see
news of November 13, 2017). It can
simultaneously detect CTX-M groups 1, 2, 8, 9 and 25. In a recent study, the test showed sensitivity and specificity above 98% on a collection of enterobacteria colonies already characterized (by PCR) for their beta-lactamase content. The same results were obtained with colonies and blood cultures derived from clinical samples containing enterobacteria (see
news of November 19, 2020). Despite this excellent performance, the CTX-M-MULTI test may not detect some very rare enzymes. To overcome this shortcoming, SPI together with an
AP-HP team has recently developed another type of strip test, the
LFIA-CTX test, based on the
detection not of the bacterial enzyme responsible for the hydrolysis of the antibiotic but
of the hydrolysis itself (cefotaxime).
Recently, researchers have developed another test strip, named
LFIA Rapid ESC, which
combines the two previous tests
. It is very efficient and inexpensive (less than 15 euros), and displays its results rapidly, i.e. within 10 minutes after a 30-minute incubation, and also offers 100% sensitivity and specificity.
Christian Moguet, Camille Gonzalez,
Stéphanie Gelhaye, Thierry Naas,
Stéphanie Simon and
Detection of expanded-spectrum cephalosporin hydrolysis by lateral flow immunoassay |
Microbial biotechnology, 2022 Feb;15(2):603-612.
Christian Moguet, Camille Gonzalez, Thierry Naas,
Stéphanie Simon and
Multiplex Lateral Flow Immunoassay for the Detection of Expanded-Spectrum Hydrolysis and CTX-M Enzymes. |
Diagnostics 2022, 12, 190.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.